181 related articles for article (PubMed ID: 36558080)
21. Aloe emodin 3-O-glucoside inhibits cell growth and migration and induces apoptosis of non-small-cell lung cancer cells via suppressing MEK/ERK and Akt signalling pathways.
Kim HJ; Choi JW; Ree J; Lim JS; Lee J; Kim JI; Thapa SB; Sohng JK; Park YI
Life Sci; 2022 Jul; 300():120495. PubMed ID: 35341826
[TBL] [Abstract][Full Text] [Related]
22. Dolutegravir derivative inhibits proliferation and induces apoptosis of non-small cell lung cancer cells via calcium signaling pathway.
Wang WJ; Mao LF; Lai HL; Wang YW; Jiang ZB; Li W; Huang JM; Xie YJ; Xu C; Liu P; Li YM; Leung ELH; Yao XJ
Pharmacol Res; 2020 Nov; 161():105129. PubMed ID: 32783976
[TBL] [Abstract][Full Text] [Related]
23. Anti-cancer effect of tectochrysin in NSCLC cells through overexpression of death receptor and inactivation of STAT3.
Oh SB; Hwang CJ; Song SY; Jung YY; Yun HM; Sok CH; Sung HC; Yi JM; Park DH; Ham YW; Han SB; Hwang BY; Hong JT
Cancer Lett; 2014 Oct; 353(1):95-103. PubMed ID: 25083589
[TBL] [Abstract][Full Text] [Related]
24. Utilizing Bioinformatics Technology to Explore the Potential Mechanism of Danggui Buxue Decoction against NSCLC.
Yu B; Lv G; Sohail M; Li Z; Li Y; Yu M; Sun F; Xu H
Dis Markers; 2022; 2022():5296830. PubMed ID: 35256890
[TBL] [Abstract][Full Text] [Related]
25. [Molecular mechanism of Spatholobi Caulis in treatment of lung cancer based on network pharmacology and molecular docking].
Chen K; Jin C; Cheng YY; Zhang QX; Li XX; Zhang L
Zhongguo Zhong Yao Za Zhi; 2021 Feb; 46(4):837-844. PubMed ID: 33645088
[TBL] [Abstract][Full Text] [Related]
26. Exploration in the mechanism of fucosterol for the treatment of non-small cell lung cancer based on network pharmacology and molecular docking.
Li X; Lin B; Lin Z; Ma Y; Wang Q; Zheng Y; Cui L; Luo H; Luo L
Sci Rep; 2021 Mar; 11(1):4901. PubMed ID: 33649481
[TBL] [Abstract][Full Text] [Related]
27. Network pharmacology and molecular docking reveal the mechanism of Scopoletin against non-small cell lung cancer.
Yuan C; Wang MH; Wang F; Chen PY; Ke XG; Yu B; Yang YF; You PT; Wu HZ
Life Sci; 2021 Apr; 270():119105. PubMed ID: 33497736
[TBL] [Abstract][Full Text] [Related]
28. Identifying druggable targets from active constituents of Azadirachta indica A. Juss. for non-small cell lung cancer using network pharmacology and validation through molecular docking.
Nath R; Baishya S; Nath D; Nahar L; Sarker SD; Choudhury MD; Talukdar AD
Phytochem Anal; 2023 Oct; 34(7):855-868. PubMed ID: 37337376
[TBL] [Abstract][Full Text] [Related]
29. Integrated omics profiling and network pharmacology uncovers the prognostic genes and multi-targeted therapeutic bioactives to combat lung cancer.
Muthuramalingam P; Akassh S; Rithiga SB; Prithika S; Gunasekaran R; Shin H; Kumar R; Baskar V; Kim J
Eur J Pharmacol; 2023 Feb; 940():175479. PubMed ID: 36566006
[TBL] [Abstract][Full Text] [Related]
30. Integrating network pharmacology and experimental models to investigate the mechanisms of dihydroartemisinin in preventing NSCLC progression via mTOR/HIF-1α signaling.
Li Y; Xiao X; Wang H; Zhou Q; Jin Z; Zhang Y; Wang Y; Yue F; Zhou S; Yang J
Eur J Pharmacol; 2021 Oct; 909():174411. PubMed ID: 34390710
[TBL] [Abstract][Full Text] [Related]
31. miR-202 Enhances the Anti-Tumor Effect of Cisplatin on Non-Small Cell Lung Cancer by Targeting the Ras/MAPK Pathway.
Sun W; Ping W; Tian Y; Zou W; Liu J; Zu Y
Cell Physiol Biochem; 2018; 51(5):2160-2171. PubMed ID: 30522099
[TBL] [Abstract][Full Text] [Related]
32. Combination of Gentiana rhodantha and Gerbera anandria in the BL02 formula as therapeutics to non-small cell lung carcinoma acting via Rap1/cdc42 signaling: A transcriptomics/ bio-informatics biological validation approach.
Tan HY; Ho VW; Chan YT; Zhang C; Wang N; Xia W; Feng Y
Pharmacol Res; 2020 May; 155():104415. PubMed ID: 31465829
[TBL] [Abstract][Full Text] [Related]
33. An anthraquinone derivative from Luffa acutangula induces apoptosis in human lung cancer cell line NCI-H460 through p53-dependent pathway.
Vanajothi R; Srinivasan P
J Recept Signal Transduct Res; 2016; 36(3):292-302. PubMed ID: 26585176
[TBL] [Abstract][Full Text] [Related]
34. Identification of downstream signaling cascades of ACK1 and prognostic classifiers in non-small cell lung cancer.
Zhu J; Liu Y; Zhao M; Cao K; Ma J; Peng S
Aging (Albany NY); 2021 Jan; 13(3):4482-4502. PubMed ID: 33495411
[No Abstract] [Full Text] [Related]
35. Suppression of reactive oxygen species-mediated ERK and JNK activation sensitizes dihydromyricetin-induced mitochondrial apoptosis in human non-small cell lung cancer.
Kao SJ; Lee WJ; Chang JH; Chow JM; Chung CL; Hung WY; Chien MH
Environ Toxicol; 2017 Apr; 32(4):1426-1438. PubMed ID: 27539140
[TBL] [Abstract][Full Text] [Related]
36. Effects of insulin-like growth factor binding protein-3 and farnesyltransferase inhibitor SCH66336 on Akt expression and apoptosis in non-small-cell lung cancer cells.
Lee HY; Moon H; Chun KH; Chang YS; Hassan K; Ji L; Lotan R; Khuri FR; Hong WK
J Natl Cancer Inst; 2004 Oct; 96(20):1536-48. PubMed ID: 15494604
[TBL] [Abstract][Full Text] [Related]
37. [Effect of "Hedyotis Diffusae Herba-Smilacis Glabrae Rhizoma" in treatment of lung adenocarcinoma based on network pharmacology].
Li JL; Hou W
Zhongguo Zhong Yao Za Zhi; 2021 Dec; 46(23):6261-6270. PubMed ID: 34951253
[TBL] [Abstract][Full Text] [Related]
38. Variable apoptotic response of NSCLC cells to inhibition of the MEK/ERK pathway by small molecules or dominant negative mutants.
Brognard J; Dennis PA
Cell Death Differ; 2002 Sep; 9(9):893-904. PubMed ID: 12181740
[TBL] [Abstract][Full Text] [Related]
39. Cisplatin-induced apoptosis in non-small-cell lung cancer cells is dependent on Bax- and Bak-induction pathway and synergistically activated by BH3-mimetic ABT-263 in p53 wild-type and mutant cells.
Matsumoto M; Nakajima W; Seike M; Gemma A; Tanaka N
Biochem Biophys Res Commun; 2016 Apr; 473(2):490-6. PubMed ID: 26996126
[TBL] [Abstract][Full Text] [Related]
40. A New Series of Triazolothiadiazines as Potential Anticancer Agents for Targeted Therapy of Non-Small Cell Lung and Colorectal Cancers: Design, Synthesis, In silico and In vitro Studies Providing Mechanistic Insight into Their Anticancer Potencies.
Sever B; Altıntop MD; Çiftçi GA; Özdemir A
Med Chem; 2021; 17(10):1104-1128. PubMed ID: 33087032
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
